
Mindfulness-Oriented Recovery Enhancement (MORE): MORE Relief from Pain and Addiction with a Neuroscience-Informed Mind-Body Approach
Presented by Eric Garland, PhD, LCSW
Friday, March 14, 2025
9am-10:30am PT/ 11am-12:30pm CT/ 12pm-1:30pm ET
Event held online via Zoom, link to access provided upon registration.
Half of all people with a substance use disorder (SUD) have chronic pain, and more than a third have a co-occurring psychiatric disorder. Unfortunately, there are few evidence-based therapies that can simultaneously treat this complex comorbidity. To meet this need, Mindfulness-Oriented Recovery Enhancement (MORE) was generated through a decade-long treatment development process funded by the National Institutes of Health (NIH). Rooted in affective neuroscience and informed by Ericksonian indirect suggestion, MORE unites mindfulness training with cognitive-behavioral therapy and principles from positive psychology into an integrative, mind-body therapy designed to target addiction, emotional distress, and pain.
This session will detail the theory underlying MORE, research data demonstrating MORE’s effectiveness, and unique clinical skills integral to this novel treatment. MORE has been tested in +1300 patients in 12 clinical trials funded by more than $70 million in research grants from NIH and the Department of Defense. In the largest randomized trial of MORE (N=250), MORE decreased opioid misuse by 45% by 9-month follow-up, nearly tripling the effect of standard psychotherapy, while simultaneously reducing chronic pain, depression, and PTSD symptoms. Mechanistic studies have shown that MORE enhances neural markers of self-regulation, increases neurophysiological responses to natural healthy rewards, and decreases craving responses in the brain. Given MORE’s clear clinical efficacy, it is now time to disseminate this evidence-based treatment widely on the national and international scale.
Zoom link will be available on course page in “My Courses” upon event registration.
This program, when attended in its entirety, offers 1.5 CEs for Psychologists, 1.5 IL CEUS for Counselors and Social Workers, or 1.5 BBS California CEUs for LPCCs, LPSWs, and LMFTs.
Half of all people with a substance use disorder (SUD) have chronic pain, and more than a third have a co-occurring psychiatric disorder. Unfortunately, there are few evidence-based therapies that can simultaneously treat this complex comorbidity. To meet this need, Mindfulness-Oriented Recovery Enhancement (MORE) was generated through a decade-long treatment development process funded by the National Institutes of Health (NIH). Rooted in affective neuroscience and informed by Ericksonian indirect suggestion, MORE unites mindfulness training with cognitive-behavioral therapy and principles from positive psychology into an integrative, mind-body therapy designed to target addiction, emotional distress, and pain.
This session will detail the theory underlying MORE, research data demonstrating MORE’s effectiveness, and unique clinical skills integral to this novel treatment. MORE has been tested in +1300 patients in 12 clinical trials funded by more than $70 million in research grants from NIH and the Department of Defense. In the largest randomized trial of MORE (N=250), MORE decreased opioid misuse by 45% by 9-month follow-up, nearly tripling the effect of standard psychotherapy, while simultaneously reducing chronic pain, depression, and PTSD symptoms. Mechanistic studies have shown that MORE enhances neural markers of self-regulation, increases neurophysiological responses to natural healthy rewards, and decreases craving responses in the brain. Given MORE’s clear clinical efficacy, it is now time to disseminate this evidence-based treatment widely on the national and international scale.
After attending this intermediate-level program, participants will be able to:
- Identify two cognitive, affective, and neurobiological mechanisms implicated in substance use disorders, affective disorders, and chronic pain.
- Explain two therapeutic techniques to reduce craving, regulate addictive behavior, decrease negative emotions, and/or manage chronic pain.
- Describe the clinical outcomes of MORE for opioid misuse and chronic pain.
This program meets APA’s continuing education STANDARD 1.1: Program content focuses on application of psychological assessment and/or intervention methods that have overall consistent and credible empirical support in the contemporary peer reviewed scientific literature beyond those publications and other types of communications devoted primarily to the promotion of the approach.
This program meets APA’s continuing education GOAL 1: Program is relevant to psychological practice, education, and/or science.
General Admission: $65.00
SCEH Members: $55.00
Students: $15.00*
(Please email [email protected] for coupon code)
Refund Policy: 100% of tuition is refundable up to 48 hours before the program. Within 48 hours of the program, and at any point in Homestudy format, tuition is nonrefundable.
Eric Garland, PhD, LCSW, Endowed Professor in Health Sciences | T. Denny Sanford Institute for Empathy and Compassion Professor | Department of Psychiatry | Center for Addiction Science and Treatment Director | UCSD ONEMIND (Optimized Neuroscience-Enhanced Mindfulness Intervention Design) University of California San Diego
Dr. Eric Garland, PhD, LCSW is Distinguished Endowed Chair in Research, Distinguished Professor, and Associate Dean for Research in the University of Utah College of Social Work and Director of the Center on Mindfulness and Integrative Health Intervention Development (C-MIIND). Dr. Garland is the developer of an innovative mindfulness-based therapy founded on insights derived from neuroscience, called Mindfulness-Oriented Recovery Enhancement (MORE). He has published more than 250 scientific articles and received more than $80 million in research grants from the National Institutes of Health (NIH) and the Department of Defense (DOD) develop and test novel mindfulness-based treatments for addiction. In 2019 was appointed by NIH Director Dr. Francis Collins to the NIH HEAL Multi-Disciplinary Working Group comprised of national experts on pain and addiction research to help guide the nation’s $2+ billion HEAL initiative to use science to halt the opioid crisis. In addition to being a clinical researcher, Dr. Garland is a licensed psychotherapist and Distinguished Fellow of the National Academies of Practice, with more than 20 years of clinical experience treating addiction. In a recent bibliometric analysis of mindfulness research published over the past 55 years, Dr. Garland was found to be the most prolific author of mindfulness research in the world.
Cooperman, N.A., Lu, S., Hanley, A.W., Puvananayagam, T., Dooley-Budsock, P., Kline, A., & Garland, E.L. (2024). Telehealth Mindfulness-Oriented Recovery Enhancement versus methadone treatment-as-usual in individuals with opioid use disorder and pain: A randomized clinical trial. JAMA Psychiatry, 81(4), 338-346.
Garland, E.L. (2024). Mindfulness-Oriented Recovery Enhancement: An Evidence-Based Treatment for Chronic Pain and Opioid Use. New York, NY: Guilford Press.
Garland, E.L., Nakamura, Y., Bryan, C.J., Hanley, A.W., Parisi, A., Froeliger, B., Marchand, W.R., & Donaldson, G.W.(2024). Mindfulness-Oriented Recovery Enhancement for veterans and military personnel on long-term opioid therapy for chronic pain: A randomized clinical trial. American Journal of Psychiatry, 181, 125-134.
Garland, E.L., Hanley, A.W., Nakamura, Y., Barrett, J.W., Baker, A.K., Reese, S.E., Riquino, M.R., Froeliger, B., & Donaldson, G.W. (2022). Mindfulness-Oriented Recovery Enhancement versus supportive group therapy for co-occurring opioid misuse and chronic pain in primary care: A randomized clinical trial. JAMA Internal Medicine, 182(4), 407-417.
Garland, E.L., Hanley, A.W., Hudak, J., Nakamura, Y., Froeliger, B. (2022). Mindfulness-induced endogenous theta stimulation occasions self-transcendence and inhibits addictive behavior. Science Advances, 8(41), eabo4455.
Garland, E.L., Atchley, R.M., Hanley, A.W., Zubieta, J.K., & Froeliger, B. (2019). Mindfulness-Oriented Recovery Enhancement remediates hedonic dysregulation in opioid users: Neural and affective evidence of target engagement. Science Advances, 5(10), eaax1569.
Target Audience: Hypnosis practitioners, healthcare professionals, mental health professionals, researchers, students.
Psychologists. This program, when attended in its entirety, is available for 1.5 continuing education credits. The Chicago School of Professional Psychology is approved by the American Psychological Association to sponsor continuing education for psychologists. The Chicago School of Professional Psychology maintains responsibility for this program and its content. The Chicago School of Professional Psychology is committed to accessibility and non-discrimination in its continuing education activities. The Chicago School of Professional Psychology is also committed to conducting all activities in conformity with the American Psychological Association’s Ethical Principles for Psychologists. Participants are asked to be aware of the need for privacy and confidentiality throughout the program. If program content becomes stressful, participants are encouraged to process these feelings during discussion periods.
Counselors/Clinical Counselors. This program, when attended in its entirety, is available for 1.5 hours of continuing education. The Chicago School of Professional Psychology is licensed by the Illinois Department of Financial and Professional Regulation (IDFPR) to provide continuing education programming for counselors and clinical counselors. License Number: 197.000159
Social Workers. This program, when attended in its entirety, is available for 1.5 hours of continuing education. The Chicago School of Professional Psychology is licensed by the Illinois Department of Financial and Professional Regulation (IDFPR) to provide continuing education programming for social workers. License Number: 159.001036
MFTs, LPCCs, and LCSWs. Course meets the qualifications for 1.5 hours of continuing education credit for MFTs, LPCCs, and/or LCSWs as required by the California Board of Behavioral Sciences. If you are licensed outside of California please check with your local licensing agency to to determine if they will accept these CEUs. The Chicago School of Professional Psychology is approved by the California Board of Behavioral Sciences (BBS) to offer continuing education programming for MFTs, LPCCs, LEPs, and/or LCSWs. The Chicago School of Professional Psychology is an accredited or approved postsecondary institution that meets the requirements set forth in Sections 4980.54(f)(1), 4989.34, 4996.22(d)(1), or 4999.76(d) of the Code.
Non-Psychologists. Most licensing boards accept Continuing Education Credits sponsored by the American Psychological Association but non-psychologists are recommended to consult with their specific state-licensing board to ensure that APA-sponsored CE is acceptable.
*Participants must attend 100% of the program in order to obtain a Certificate of Attendance.
If participants have special needs, we will attempt to accommodate them. Please address questions, concerns and any complaints to [email protected]. There is no commercial support for this program nor are there any relationships between the CE Sponsor, presenting organization, presenter, program content, research, grants, or other funding that could reasonably be construed as conflicts of interest.